Not provided
Not provided
Not provided
Not provided
Not provided
Doctoral student running the study left for internship and did not finish the study
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study tests the effectiveness of exposure therapy for fear of spiders as enhanced by the use of antagonistic or opposite actions during treatment. The goal of the study is to compare the efficacy threat-relevant opposite actions and threat-irrelevant opposite actions in extinguishing fear.
This study tests whether exposure therapy for fear of spiders can be enhanced with the use of opposite actions, which are actions opposite to fear-related action tendencies. The investigators will test two sub-types of opposite actions (a) threat-relevant opposite actions, which are actions antagonistic to specific threats associated with spider phobia, and (b) threat-irrelevant opposite actions, which are actions antagonistic to the fear response, but unrelated to specific threats associated with spider phobia. This exposure therapy enhanced with opposite actions will be compared with two control groups: standard exposure therapy and non-specific anxiety treatment (biofeedback relaxation training).
Individuals between the ages of 18-65 with elevated fear of spiders are randomly assigned to one of four treatment conditions (1) biofeedback relaxation training, (2) standard exposure therapy, (3) exposure therapy with threat-relevant opposite actions, and (4) exposure therapy with threat-irrelevant opposite actions. All participants undergo an online prescreen and a face-to-face screening assessment to determine eligibility and baseline (pre-treatment) symptom severity. Participants additionally complete assessments directly after treatment (post-treatment), and approximately two weeks after treatment (follow-up). The pre-treatment assessment occurs on the same day as treatment, the post-treatment assessment occurs during the treatment visit as soon as the treatment procedure is complete, and the follow-up assessment occurs within a window of 14-21 days after the completion of treatment. Participants complete two behavioral approach tests (in the treatment context and in the generalization context) at pre-treatment, post-treatment, and follow-up. Participants complete a battery of self-report questionnaires at pre-treatment and follow-up.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Biofeedback | Active Comparator | Biofeedback Relaxation Training |
|
| Standard Exposure | Active Comparator | Exposure Therapy |
|
| Exposure with Threat-Relevant OAs. | Experimental | Exposure with Threat-Relevant Opposite Actions |
|
| Exposure with Threat-Irrelevant OAs | Experimental | Exposure with Threat-Irrelevant Opposite Actions |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Biofeedback Relaxation Training | Behavioral | Participants will receive one-session biofeedback relaxation training (24 minutes) for anxiety reduction. Prior to biofeedback, participants will receive education about spiders and the development and maintenance of spider phobia. |
| Measure | Description | Time Frame |
|---|---|---|
| Change in Performance on a Behavioral Approach Test in a Generalization Context (Pre-treatment to 2-week Follow-Up) | Change in peak subjective fear (0 - 100 scale), behavioral approach (0 - 13 scale), and physiological reactivity (heart rate and skin conductance) to a live spider not used during treatment (generalization context) from pre-treatment to follow-up | Change from pre-treatment (same day as treatment) to follow-up (window of 14-21 days after treatment) |
| Measure | Description | Time Frame |
|---|---|---|
| Change in Performance on a Behavioral Approach Test in a Generalization Context (Pre-treatment to Post-treatment) | Change in peak subjective fear (0 - 100 scale), behavioral approach (0 - 13 scale), and physiological reactivity (heart rate and skin conductance) to a live spider not used during treatment (generalization context) from pre-treatment to post-treatment. | Change from pre-treatment (same day as treatment) to post-treatment (within 30 minutes of completion of the treatment procedure) |
Not provided
Inclusion Criteria:
At Prescreen:
At Screening visit: inability to complete close approach toward spiders as determined by the treatment context and generalization context Behavioral Approach Tests
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Michael J Telch, PhD | The University of Texas at Austin | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Laboratory for the Study of Anxiety Disorders, University of Texas at Austin | Austin | Texas | 78712 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| C562465 | Phobia, Specific |
| C000719193 | Arachnophobia |
| C000719220 | Zoophobia |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D007171 | Implosive Therapy |
| ID | Term |
|---|---|
| D003887 | Desensitization, Psychologic |
| D001521 | Behavior Therapy |
| D011613 | Psychotherapy |
| D004191 | Behavioral Disciplines and Activities |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Exposure Therapy | Behavioral | Participants will receive one-session exposure therapy (24 minutes) for fear of spiders. Prior to exposure therapy, participants will receive education about spiders and the development and the development and maintenance of spider phobia. |
|
| Exposure with Threat-Relevant Opposite Actions | Behavioral | Participants will receive one-session exposure therapy (24 minutes) for fear of spiders. During exposure, participants will engage in actions opposite to the tendencies associated with threat avoidance. Prior to exposure therapy, participants will receive education about spiders and the development and maintenance of spider phobia. |
|
| Exposure with Threat-Irrelevant Opposite Actions | Behavioral | Participants will receive one-session exposure therapy (24 minutes) for fear of spiders. During exposure therapy, participants will engage in actions opposite of the action tendencies associated with the fear, but unrelated to the specific threats associated with spider phobia. Prior to exposure therapy, participants will receive education about spiders and the development and maintenance of spider phobia. |
|
| Change in Performance on a Behavioral Approach Test in the Treatment Context (Pre-treatment to 2-week Follow-Up) | Change in peak subjective fear (0 - 100), behavioral approach (0 - 10), and physiological reactivity (heart rate and skin conductance) to a live spider used during treatment (treatment context) from pre-treatment to follow-up | Change from pre-treatment (same day as treatment) to follow-up (window of 14-21 days after treatment) |
| Change in Performance on a Behavioral Approach Test in the Treatment Context (Pre-treatment to Post-treatment) | Change in peak subjective fear (0 - 100), behavioral approach (0 - 10), and physiological reactivity (heart rate and skin conductance) to a live spider used during treatment (treatment context) from pre-treatment to post-treatment. | Change from pre-treatment (same day as treatment) to post-treatment (within 30 minutes of completion of the treatment procedure) |
| Change in Fear of Spiders Questionnaire (Pre-treatment to 2-week Follow-Up) | Change in psychometrically validated questionnaire assessing spider phobia severity from pre-treatment to follow-up. | Change from pre-treatment (same day as treatment) to follow-up (window of 14-21 days after treatment) |
| Change in Armfield and Mattiske Disgust Questionnaire (Pre-treatment to 2-week Follow-Up) | Change in psychometrically validated questionnaire assessing severity of disgust response related to spider phobia from pre-treatment to follow-up. | Change from pre-treatment (same day as treatment) to follow-up (window of 14-21 days after treatment) |
| Change in Spider Belief Questionnaire from pre-treatment to follow-up (Pre-treatment to 2-Week Follow-Up) | Change in psychometrically validated questionnaire assessing cognitions related to spider phobia from pre-treatment to follow-up. | Change from pre-treatment (same day as treatment) to follow-up (window of 14-21 days after treatment) |